Home/ Supplements/ Vitamin K/ MK-7 Vitamin K-2 Extra Strength - 300 mc...

MK-7 Vitamin K-2 Extra Strength - 300 mcg

product on market Capsule NOW Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 (MK-7) is supported by moderate to strong evidence for promoting calcium deposition in bones and preventing arterial calcification. Research indicates it works synergistically with Vitamin D to improve bone mineral density. The evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for MK-7 Vitamin K-2 Extra Strength - 300 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veg Capsule(s)
Serving Size
120
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

300 mcg
2.5× RDA — within safe limits 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Hypromellose Silicon Dioxide Medium Chain Triglycerides
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Take 1 capsule daily with a meal.

Warnings & Precautions

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication (especially anti-coagulant drugs such as warfarin, Coumadin, heparin), or have a medical condition.

Keep out of reach of children.

Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish or sesame ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Formulation Notes

Vitamin K is well known for its role in the synthesis of a number of blood coagulation factors and is also important for the formation of strong, healthy bones. MenaQ7 MK-7 is a unique soy-free, bioavailable form of vitamin K2 that plays a critical role in arterial health through its ability to support proper calcium metabolism in blood vessels and arteries.

Natural color variation may occur in this product.

Crescent H (Halal)

Supports bone health Cardiovascular support

MenaQ7

Vegetarian/Vegan

Non-GMO

Made and quality tested in the USA with globally sourced ingredients.

Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish or sesame ingredients.

This extra strength product has three times the vitamin K2 as in our regular strength product (100 mcg).

Additional Information

Crescent H (Halal) GMP Quality Assured

Vitamins Family owned since 1968.

Store in a cool, dry place after opening.

This bottle is made from 100% PCR (post-consumer recycled) resin.

Metadata

Product Details

UPC / SKU7 33739 00994 4
DSLD Entry Date2024-10-24
Product TypeVitamin
FormCapsule
BrandNOW
DSLD ID313799
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.